150 related articles for article (PubMed ID: 37023758)
1. Trans-amplifying RNA: Translational application in gene therapy.
Lundstrom K
Mol Ther; 2023 Jun; 31(6):1507-1508. PubMed ID: 37023758
[No Abstract] [Full Text] [Related]
2. SMaRT for Therapeutic Purposes.
Riedmayr LM
Methods Mol Biol; 2020; 2079():219-232. PubMed ID: 31728974
[TBL] [Abstract][Full Text] [Related]
3. Cancer-type organic anion transporting polypeptide 1B3 is a target for cancer suicide gene therapy using RNA trans-splicing technology.
Sun Y; Piñón Hofbauer J; Harada M; Wöss K; Koller U; Morio H; Stierschneider A; Kitamura K; Hashimoto M; Chiba K; Akita H; Anzai N; Reichelt J; Bauer JW; Guttmann-Gruber C; Furihata T
Cancer Lett; 2018 Oct; 433():107-116. PubMed ID: 29960051
[TBL] [Abstract][Full Text] [Related]
4. Repair of rhodopsin mRNA by spliceosome-mediated RNA trans-splicing: a new approach for autosomal dominant retinitis pigmentosa.
Berger A; Lorain S; Joséphine C; Desrosiers M; Peccate C; Voit T; Garcia L; Sahel JA; Bemelmans AP
Mol Ther; 2015 May; 23(5):918-930. PubMed ID: 25619725
[TBL] [Abstract][Full Text] [Related]
5. mRNA trans-splicing in gene therapy for genetic diseases.
Berger A; Maire S; Gaillard MC; Sahel JA; Hantraye P; Bemelmans AP
Wiley Interdiscip Rev RNA; 2016 Jul; 7(4):487-98. PubMed ID: 27018401
[TBL] [Abstract][Full Text] [Related]
6. Evaluating a Targeted Cancer Therapy Approach Mediated by RNA
Woess K; Sun Y; Morio H; Stierschneider A; Kaufmann A; Hainzl S; Trattner L; Kocher T; Tockner B; Leb-Reichl V; Steiner M; Brachtl G; South AP; Bauer JW; Reichelt J; Furihata T; Wally V; Koller U; Piñón Hofbauer J; Guttmann-Gruber C
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008999
[TBL] [Abstract][Full Text] [Related]
7. RNA trans-splicing for genodermatoses.
Bauer JW; Murauer EM; Wally V; Koller U
Methods Mol Biol; 2013; 961():441-55. PubMed ID: 23325663
[TBL] [Abstract][Full Text] [Related]
8. The design and optimization of RNA trans-splicing molecules for skin cancer therapy.
Gruber C; Koller U; Murauer EM; Hainzl S; Hüttner C; Kocher T; South AP; Hintner H; Bauer JW
Mol Oncol; 2013 Dec; 7(6):1056-68. PubMed ID: 23998959
[TBL] [Abstract][Full Text] [Related]
9. The Chloroplast
Kück U; Schmitt O
Cells; 2021 Feb; 10(2):. PubMed ID: 33535503
[TBL] [Abstract][Full Text] [Related]
10. RNA Trans-Splicing Targeting Endogenous β-Globin Pre-Messenger RNA in Human Erythroid Cells.
Uchida N; Washington KN; Mozer B; Platner C; Ballantine J; Skala LP; Raines L; Shvygin A; Hsieh MM; Mitchell LG; Tisdale JF
Hum Gene Ther Methods; 2017 Apr; 28(2):91-99. PubMed ID: 28267358
[TBL] [Abstract][Full Text] [Related]
11. Genetic medicine at the RNA level: modifications of the genetic repertoire for therapeutic purposes by pre-mRNA trans-splicing.
Pergolizzi RG; Crystal RG
C R Biol; 2004 Aug; 327(8):695-709. PubMed ID: 15506518
[TBL] [Abstract][Full Text] [Related]
12. Spliceosome-mediated trans-splicing: the therapeutic cut and paste.
Wally V; Murauer EM; Bauer JW
J Invest Dermatol; 2012 Aug; 132(8):1959-66. PubMed ID: 22495179
[TBL] [Abstract][Full Text] [Related]
13. Trans-splicing adeno-associated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection efficiency.
Xu Z; Yue Y; Lai Y; Ye C; Qiu J; Pintel DJ; Duan D
Hum Gene Ther; 2004 Sep; 15(9):896-905. PubMed ID: 15353044
[TBL] [Abstract][Full Text] [Related]
14. Trans-splicing vectors expand the packaging limits of adeno-associated virus for gene therapy applications.
Duan D; Yue Y; Yan Z; Engelhardt JF
Methods Mol Med; 2003; 76():287-307. PubMed ID: 12526170
[No Abstract] [Full Text] [Related]
15. Construction and validation of an RNA trans-splicing molecule suitable to repair a large number of COL7A1 mutations.
Tockner B; Kocher T; Hainzl S; Reichelt J; Bauer JW; Koller U; Murauer EM
Gene Ther; 2016 Nov; 23(11):775-784. PubMed ID: 27434145
[TBL] [Abstract][Full Text] [Related]
16. 5'RNA
Mayr E; Ablinger M; Lettner T; Murauer EM; Guttmann-Gruber C; Piñón Hofbauer J; Hainzl S; Kaiser M; Klausegger A; Bauer JW; Koller U; Wally V
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163654
[TBL] [Abstract][Full Text] [Related]
17. RNA reprogramming and repair based on trans-splicing group I ribozymes.
Fiskaa T; Birgisdottir AB
N Biotechnol; 2010 Jul; 27(3):194-203. PubMed ID: 20219714
[TBL] [Abstract][Full Text] [Related]
18. RNA Trans-Splicing Modulation via Antisense Molecule Interference.
Liemberger B; Piñón Hofbauer J; Wally V; Arzt C; Hainzl S; Kocher T; Murauer EM; Bauer JW; Reichelt J; Koller U
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518954
[TBL] [Abstract][Full Text] [Related]
19. Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors.
Lai Y; Yue Y; Liu M; Ghosh A; Engelhardt JF; Chamberlain JS; Duan D
Nat Biotechnol; 2005 Nov; 23(11):1435-9. PubMed ID: 16244658
[TBL] [Abstract][Full Text] [Related]
20. Promiscuity of pre-mRNA spliceosome-mediated trans splicing: a problem for gene therapy?
Kikumori T; Cote GJ; Gagel RF
Hum Gene Ther; 2001 Jul; 12(11):1429-41. PubMed ID: 11485634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
